Marco L. Davila
Roswell Park Comprehensive Cancer Center(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immune Cell Function and Interaction, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia(2018)2,624 cited
- → Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia(2014)2,471 cited
- → CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia(2013)2,062 cited
- → Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias(2011)1,274 cited
- → Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism(2018)679 cited
- → Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma(2021)278 cited
- → Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome(2018)274 cited
- → Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma(2020)261 cited
- → Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events(2020)258 cited
- → High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma(2020)235 cited